IDENTIFICATION OF NEOANTIGENS WITH MHC CLASS II MODEL
A method for identifying T-cells that are antigen-specific for at least one neoantigen that is likely to be presented by class II MHC alleles on surfaces of tumor cells of a subject. Peptide sequences of tumor neoantigens are obtained by sequencing the tumor cells of the subject. The peptide sequenc...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre ; ger |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | YELENSKY, Roman PALMER, Christine BULIK-SULLIVAN, Brendan SKOBERNE, Mojca YOUNG, Lauren Elizabeth FRANCIS, Joshua Michael BUSBY, Jennifer CAO, Minh Duc DAVIS, Matthew Joseph BOUCHER, Thomas Francis |
| description | A method for identifying T-cells that are antigen-specific for at least one neoantigen that is likely to be presented by class II MHC alleles on surfaces of tumor cells of a subject. Peptide sequences of tumor neoantigens are obtained by sequencing the tumor cells of the subject. The peptide sequences are input into a machine-learned presentation model to generate presentation likelihoods for the tumor neoantigens, each presentation likelihood representing the likelihood that a neoantigen is presented by the class II MHC alleles on the surfaces of the tumor cells of the subject. A subset of the neoantigens is selected based on the presentation likelihoods. T-cells that are antigen-specific for at least one of the neoantigens in the subset are identified. These T-cells can be expanded for use in T-cell therapy. TCRs of these identified T-cells can also be sequenced and cloned into new T-cells for use in T-cell therapy. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP3935071A4</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP3935071A4</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP3935071A43</originalsourceid><addsrcrecordid>eNrjZDD1dHH1C_F083R2DPH091Pwd1Pwc_V3BAq5u_oFK4R7hngo-Ho4Kzj7OAYHK3h6Kvj6u7j68DCwpiXmFKfyQmluBgU31xBnD93Ugvz41OKCxOTUvNSSeNcAY0tjUwNzQ0cTYyKUAACMmScJ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>IDENTIFICATION OF NEOANTIGENS WITH MHC CLASS II MODEL</title><source>esp@cenet</source><creator>YELENSKY, Roman ; PALMER, Christine ; BULIK-SULLIVAN, Brendan ; SKOBERNE, Mojca ; YOUNG, Lauren Elizabeth ; FRANCIS, Joshua Michael ; BUSBY, Jennifer ; CAO, Minh Duc ; DAVIS, Matthew Joseph ; BOUCHER, Thomas Francis</creator><creatorcontrib>YELENSKY, Roman ; PALMER, Christine ; BULIK-SULLIVAN, Brendan ; SKOBERNE, Mojca ; YOUNG, Lauren Elizabeth ; FRANCIS, Joshua Michael ; BUSBY, Jennifer ; CAO, Minh Duc ; DAVIS, Matthew Joseph ; BOUCHER, Thomas Francis</creatorcontrib><description>A method for identifying T-cells that are antigen-specific for at least one neoantigen that is likely to be presented by class II MHC alleles on surfaces of tumor cells of a subject. Peptide sequences of tumor neoantigens are obtained by sequencing the tumor cells of the subject. The peptide sequences are input into a machine-learned presentation model to generate presentation likelihoods for the tumor neoantigens, each presentation likelihood representing the likelihood that a neoantigen is presented by the class II MHC alleles on the surfaces of the tumor cells of the subject. A subset of the neoantigens is selected based on the presentation likelihoods. T-cells that are antigen-specific for at least one of the neoantigens in the subset are identified. These T-cells can be expanded for use in T-cell therapy. TCRs of these identified T-cells can also be sequenced and cloned into new T-cells for use in T-cell therapy.</description><language>eng ; fre ; ger</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20221221&DB=EPODOC&CC=EP&NR=3935071A4$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20221221&DB=EPODOC&CC=EP&NR=3935071A4$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>YELENSKY, Roman</creatorcontrib><creatorcontrib>PALMER, Christine</creatorcontrib><creatorcontrib>BULIK-SULLIVAN, Brendan</creatorcontrib><creatorcontrib>SKOBERNE, Mojca</creatorcontrib><creatorcontrib>YOUNG, Lauren Elizabeth</creatorcontrib><creatorcontrib>FRANCIS, Joshua Michael</creatorcontrib><creatorcontrib>BUSBY, Jennifer</creatorcontrib><creatorcontrib>CAO, Minh Duc</creatorcontrib><creatorcontrib>DAVIS, Matthew Joseph</creatorcontrib><creatorcontrib>BOUCHER, Thomas Francis</creatorcontrib><title>IDENTIFICATION OF NEOANTIGENS WITH MHC CLASS II MODEL</title><description>A method for identifying T-cells that are antigen-specific for at least one neoantigen that is likely to be presented by class II MHC alleles on surfaces of tumor cells of a subject. Peptide sequences of tumor neoantigens are obtained by sequencing the tumor cells of the subject. The peptide sequences are input into a machine-learned presentation model to generate presentation likelihoods for the tumor neoantigens, each presentation likelihood representing the likelihood that a neoantigen is presented by the class II MHC alleles on the surfaces of the tumor cells of the subject. A subset of the neoantigens is selected based on the presentation likelihoods. T-cells that are antigen-specific for at least one of the neoantigens in the subset are identified. These T-cells can be expanded for use in T-cell therapy. TCRs of these identified T-cells can also be sequenced and cloned into new T-cells for use in T-cell therapy.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDD1dHH1C_F083R2DPH091Pwd1Pwc_V3BAq5u_oFK4R7hngo-Ho4Kzj7OAYHK3h6Kvj6u7j68DCwpiXmFKfyQmluBgU31xBnD93Ugvz41OKCxOTUvNSSeNcAY0tjUwNzQ0cTYyKUAACMmScJ</recordid><startdate>20221221</startdate><enddate>20221221</enddate><creator>YELENSKY, Roman</creator><creator>PALMER, Christine</creator><creator>BULIK-SULLIVAN, Brendan</creator><creator>SKOBERNE, Mojca</creator><creator>YOUNG, Lauren Elizabeth</creator><creator>FRANCIS, Joshua Michael</creator><creator>BUSBY, Jennifer</creator><creator>CAO, Minh Duc</creator><creator>DAVIS, Matthew Joseph</creator><creator>BOUCHER, Thomas Francis</creator><scope>EVB</scope></search><sort><creationdate>20221221</creationdate><title>IDENTIFICATION OF NEOANTIGENS WITH MHC CLASS II MODEL</title><author>YELENSKY, Roman ; PALMER, Christine ; BULIK-SULLIVAN, Brendan ; SKOBERNE, Mojca ; YOUNG, Lauren Elizabeth ; FRANCIS, Joshua Michael ; BUSBY, Jennifer ; CAO, Minh Duc ; DAVIS, Matthew Joseph ; BOUCHER, Thomas Francis</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP3935071A43</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2022</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>YELENSKY, Roman</creatorcontrib><creatorcontrib>PALMER, Christine</creatorcontrib><creatorcontrib>BULIK-SULLIVAN, Brendan</creatorcontrib><creatorcontrib>SKOBERNE, Mojca</creatorcontrib><creatorcontrib>YOUNG, Lauren Elizabeth</creatorcontrib><creatorcontrib>FRANCIS, Joshua Michael</creatorcontrib><creatorcontrib>BUSBY, Jennifer</creatorcontrib><creatorcontrib>CAO, Minh Duc</creatorcontrib><creatorcontrib>DAVIS, Matthew Joseph</creatorcontrib><creatorcontrib>BOUCHER, Thomas Francis</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>YELENSKY, Roman</au><au>PALMER, Christine</au><au>BULIK-SULLIVAN, Brendan</au><au>SKOBERNE, Mojca</au><au>YOUNG, Lauren Elizabeth</au><au>FRANCIS, Joshua Michael</au><au>BUSBY, Jennifer</au><au>CAO, Minh Duc</au><au>DAVIS, Matthew Joseph</au><au>BOUCHER, Thomas Francis</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>IDENTIFICATION OF NEOANTIGENS WITH MHC CLASS II MODEL</title><date>2022-12-21</date><risdate>2022</risdate><abstract>A method for identifying T-cells that are antigen-specific for at least one neoantigen that is likely to be presented by class II MHC alleles on surfaces of tumor cells of a subject. Peptide sequences of tumor neoantigens are obtained by sequencing the tumor cells of the subject. The peptide sequences are input into a machine-learned presentation model to generate presentation likelihoods for the tumor neoantigens, each presentation likelihood representing the likelihood that a neoantigen is presented by the class II MHC alleles on the surfaces of the tumor cells of the subject. A subset of the neoantigens is selected based on the presentation likelihoods. T-cells that are antigen-specific for at least one of the neoantigens in the subset are identified. These T-cells can be expanded for use in T-cell therapy. TCRs of these identified T-cells can also be sequenced and cloned into new T-cells for use in T-cell therapy.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre ; ger |
| recordid | cdi_epo_espacenet_EP3935071A4 |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE |
| title | IDENTIFICATION OF NEOANTIGENS WITH MHC CLASS II MODEL |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T00%3A40%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=YELENSKY,%20Roman&rft.date=2022-12-21&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP3935071A4%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |